Korean Circ J.
2015 Jul;45(4):349-349. 10.4070/kcj.2015.45.4.349.
Erratum to: Additive Beneficial Effects of Valsartan Combined with Rosuvastatin in the Treatment of Hypercholesterolemic Hypertensive Patients
- Affiliations
-
- 1Division of Cardiology and Cardiovascular Research Institute, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
- 2Division of Cardiology, Department of Internal Medicine, Daedong Hospital, Busan, Korea.
- 3Division of Cardiology, Cardiovascular Center, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.
- 4Division of Cardiology, Department of Internal Medicine, Kyung Hee University Medical Center, Seoul, Korea.
- 5Department of Cardiology, Heart Research Center of Chonnam National University Hospital, Gwangju, Korea.
- 6Department of Cardiology, Soon Chun Hyang University Bucheon Hospital, Bucheon, Korea.
- 7Department of Cardiology, Gachon University Gil Medical Center, Incheon, Korea.
- 8Division of Cardiology, Dankook University College of Medicine, Cheonan, Korea.
- 9Division of Cardiology, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, Korea.
- 10Division of Cardiology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
- 11Division of Cardiology, Department of Internal Medicine, Konyang University Hospital, Daejeon, Korea.
- 12Department of Cardiology, Ajou University Medical Center, Suwon, Korea.
- 13Division of Cardiology, Pusan National University Hospital, Busan, Korea.
- 14Division of Cardiology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
- 15Division of Cardiology, Department of Internal Medicine, Gyeongsang National University Hospital and Gyeongsang National University School of Medicine, Jinju, Korea.
- 16Department of Cardiology, Myongji Hospital Cardiovascular Center, Goyang, Korea.
- 17Division of Cardiology, Department of Internal Medicine, Yeungnam University Hospital, Daegu, Korea.
- 18Division of Cardiology, Department of Internal Medicine, SMG-SNU Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea.
- 19Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
- 20Division of Cardiology, Department of Internal Medicine, Ewha Womans University Mokdong Hospital, Seoul, Korea.
- 21Department of Cardiology, Pusan National University Yangsan Hospital, Yangsan, Korea.
- 22Division of Cardiology, Department of Internal Medicine, Inje University Ilsan Paik Hospital, Goyang, Korea.
- 23Division of Cardiology, Department of Internal Medicine, Kosin University Gospel Hospital, Busan, Korea.
- 24Clinical Development Department, LG Life Sciences Ltd., Seoul, Korea.
- KMID: 1964111
- DOI: http://doi.org/10.4070/kcj.2015.45.4.349
Abstract
- In this article, on page 230, Fig. 2A needs to be corrected.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Additive Beneficial Effects of Valsartan Combined with Rosuvastatin in the Treatment of Hypercholesterolemic Hypertensive Patients
- Rosuvastatin-induced Generalized Drug Eruption
- Addition of Amlodipine or Valsartan for Improvement of Diastolic Dysfunction Associated with Hypertension
- Effect of Rosuvastatin on Coronary Flow Reserve in Hypertensive Patients at Cardiovascular Risk
- Letter: Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2019;43:582–9)
